检索结果 - Brian Healey

Discovery of Evobrutinib: An Oral, Potent, and Highly Selective, Covalent Bruton’s Tyrosine Kinase (BTK) Inhibitor for the Treatment of Immunological Diseases 由 Richard D. Caldwell, Hui Qiu, Ben Askew, Andrew T. Bender, Nadia Brügger, Montserrat Camps, Mohanraj Dhanabal, Vikram Dutt, Thomas Eichhorn, A.S. Gardberg, Andreas Goutopoulos, Roland Grenningloh, Jared Head, Brian Healey, Brian L. Hodous, Bayard R. Huck, Theresa Johnson, Christopher C. Jones, Reinaldo Jones, Igor Mochalkin, Federica Morandi, Thi Kim Ngan Nguyen, Michael Meyring, Justin R. Potnick, Dusica Santos, Ralf Schmidt, Brian Sherer, Adam Shutes, Klaus Urbahns, Ariele Viacava Follis, Ansgar Wegener, Simone C. Zimmerli, Lesley Liu‐Bujalski